Oral Nafamostat in Healthy Volunteers (NAF-101)

NCT04406415 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Nafamostat Mesilate
DRUG: Placebo

Sponsor

Ensysce Biosciences

Collaborators

[object Object]